Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis
Guilin Zhang,1– 3,* Yanqiao Ren,1– 3,* Jiayun Liu,1– 3 Yanyan Cao,1– 3 Fu Xiong,1– 3 Bin Liang,1– 3 Chuansheng Zheng,1– 3 Xuefeng Kan1– 3 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-01-01
|
| Series: | Journal of Hepatocellular Carcinoma |
| Subjects: | |
| Online Access: | https://www.dovepress.com/transarterial-chemoembolization-plus-radiofrequency-ablation-and-iodin-peer-reviewed-fulltext-article-JHC |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841544140667486208 |
|---|---|
| author | Zhang G Ren Y Liu J Cao Y Xiong F Liang B Zheng C Kan X |
| author_facet | Zhang G Ren Y Liu J Cao Y Xiong F Liang B Zheng C Kan X |
| author_sort | Zhang G |
| collection | DOAJ |
| description | Guilin Zhang,1– 3,* Yanqiao Ren,1– 3,* Jiayun Liu,1– 3 Yanyan Cao,1– 3 Fu Xiong,1– 3 Bin Liang,1– 3 Chuansheng Zheng,1– 3 Xuefeng Kan1– 3 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Hubei Provincial Clinical Research Center for Precision Radiology & Interventional Medicine, Wuhan, 430022, People’s Republic of China; 3Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xuefeng Kan; Chuansheng Zheng, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, Hubei province, 430022, People’s Republic of China, Email xkliulang1314@163.com; hqzcsxh@sina.comBackground & Aims: The effect of transarterial chemoembolization (TACE) plus radiofrequency ablation (RFA) (TACE-RFA) for hepatocellular carcinoma (HCC) in high-risk locations is not satisfactory. The aim of this study was to compare the clinical outcomes of TACE-RFA plus iodine-125 (125I) seed implantation (TACE-RFA-125I) therapy with those of TACE-RFA for unresectable HCC (≤ 5 cm) in high-risk locations.Methods: From January 2010 to June 2023, the clinical data of 126 patients with unresectable HCC (≤ 5 cm) in high-risk locations who received TACE-RFA-125I or TACE-RFA treatment were retrospectively analyzed. The clinical outcomes between the two groups were compared after propensity score matching (PSM) analysis.Results: Forty-six pairs of patients were matched. The local progression-free survival rates at 1-, 2-, 3-, 4-, and 5-years were 100%, 82.4%, 74.8%, 63.5%, and 54% in the TACE-RFA-125I group, which were significantly higher than 91.3%, 69.4%, 50.7%, 29.4%, and 26.7% in the TACE-RFA group, respectively (p = 0.004). The median progression-free survival in the TACE-RFA-125I group was significantly longer than that in the TACE-RFA group (p = 0.002). The overall survival rates at 1-, 2-, 3-, 4-, and 5-years were 100%, 93.4%, 80.7%, 74.9%, and 64.7% in the TACE-RFA-125I group, which were significantly higher than 97.8%, 78%, 68.6%, 51.1%, and 45.3% in the TACE-RFA group, respectively (p = 0.011). There was no occurrence of major complications or procedure-related deaths in the two groups.Conclusion: Compared with the TACE-RFA treatment, TACE-RFA-125I should be a more effective treatment strategy for patients with unresectable HCC (≤ 5 cm) in high-risk locations.Keywords: radiofrequency ablation, transarterial chemoembolization, iodine-125 seed, hepatocellular carcinoma, high-risk locations |
| format | Article |
| id | doaj-art-7fe8287ede374becb9ef4946aa130a6a |
| institution | Kabale University |
| issn | 2253-5969 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Journal of Hepatocellular Carcinoma |
| spelling | doaj-art-7fe8287ede374becb9ef4946aa130a6a2025-01-12T16:52:42ZengDove Medical PressJournal of Hepatocellular Carcinoma2253-59692025-01-01Volume 12152799148Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched AnalysisZhang GRen YLiu JCao YXiong FLiang BZheng CKan XGuilin Zhang,1– 3,* Yanqiao Ren,1– 3,* Jiayun Liu,1– 3 Yanyan Cao,1– 3 Fu Xiong,1– 3 Bin Liang,1– 3 Chuansheng Zheng,1– 3 Xuefeng Kan1– 3 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Hubei Provincial Clinical Research Center for Precision Radiology & Interventional Medicine, Wuhan, 430022, People’s Republic of China; 3Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xuefeng Kan; Chuansheng Zheng, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, Hubei province, 430022, People’s Republic of China, Email xkliulang1314@163.com; hqzcsxh@sina.comBackground & Aims: The effect of transarterial chemoembolization (TACE) plus radiofrequency ablation (RFA) (TACE-RFA) for hepatocellular carcinoma (HCC) in high-risk locations is not satisfactory. The aim of this study was to compare the clinical outcomes of TACE-RFA plus iodine-125 (125I) seed implantation (TACE-RFA-125I) therapy with those of TACE-RFA for unresectable HCC (≤ 5 cm) in high-risk locations.Methods: From January 2010 to June 2023, the clinical data of 126 patients with unresectable HCC (≤ 5 cm) in high-risk locations who received TACE-RFA-125I or TACE-RFA treatment were retrospectively analyzed. The clinical outcomes between the two groups were compared after propensity score matching (PSM) analysis.Results: Forty-six pairs of patients were matched. The local progression-free survival rates at 1-, 2-, 3-, 4-, and 5-years were 100%, 82.4%, 74.8%, 63.5%, and 54% in the TACE-RFA-125I group, which were significantly higher than 91.3%, 69.4%, 50.7%, 29.4%, and 26.7% in the TACE-RFA group, respectively (p = 0.004). The median progression-free survival in the TACE-RFA-125I group was significantly longer than that in the TACE-RFA group (p = 0.002). The overall survival rates at 1-, 2-, 3-, 4-, and 5-years were 100%, 93.4%, 80.7%, 74.9%, and 64.7% in the TACE-RFA-125I group, which were significantly higher than 97.8%, 78%, 68.6%, 51.1%, and 45.3% in the TACE-RFA group, respectively (p = 0.011). There was no occurrence of major complications or procedure-related deaths in the two groups.Conclusion: Compared with the TACE-RFA treatment, TACE-RFA-125I should be a more effective treatment strategy for patients with unresectable HCC (≤ 5 cm) in high-risk locations.Keywords: radiofrequency ablation, transarterial chemoembolization, iodine-125 seed, hepatocellular carcinoma, high-risk locationshttps://www.dovepress.com/transarterial-chemoembolization-plus-radiofrequency-ablation-and-iodin-peer-reviewed-fulltext-article-JHCradiofrequency ablationtransarterial chemoembolizationiodine-125 seedhepatocellular carcinomahigh-risk locations |
| spellingShingle | Zhang G Ren Y Liu J Cao Y Xiong F Liang B Zheng C Kan X Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis Journal of Hepatocellular Carcinoma radiofrequency ablation transarterial chemoembolization iodine-125 seed hepatocellular carcinoma high-risk locations |
| title | Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis |
| title_full | Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis |
| title_fullStr | Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis |
| title_full_unstemmed | Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis |
| title_short | Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis |
| title_sort | transarterial chemoembolization plus radiofrequency ablation and iodine 125 seed implantation for hepatocellular carcinoma in high risk locations a propensity score matched analysis |
| topic | radiofrequency ablation transarterial chemoembolization iodine-125 seed hepatocellular carcinoma high-risk locations |
| url | https://www.dovepress.com/transarterial-chemoembolization-plus-radiofrequency-ablation-and-iodin-peer-reviewed-fulltext-article-JHC |
| work_keys_str_mv | AT zhangg transarterialchemoembolizationplusradiofrequencyablationandiodine125seedimplantationforhepatocellularcarcinomainhighrisklocationsapropensityscorematchedanalysis AT reny transarterialchemoembolizationplusradiofrequencyablationandiodine125seedimplantationforhepatocellularcarcinomainhighrisklocationsapropensityscorematchedanalysis AT liuj transarterialchemoembolizationplusradiofrequencyablationandiodine125seedimplantationforhepatocellularcarcinomainhighrisklocationsapropensityscorematchedanalysis AT caoy transarterialchemoembolizationplusradiofrequencyablationandiodine125seedimplantationforhepatocellularcarcinomainhighrisklocationsapropensityscorematchedanalysis AT xiongf transarterialchemoembolizationplusradiofrequencyablationandiodine125seedimplantationforhepatocellularcarcinomainhighrisklocationsapropensityscorematchedanalysis AT liangb transarterialchemoembolizationplusradiofrequencyablationandiodine125seedimplantationforhepatocellularcarcinomainhighrisklocationsapropensityscorematchedanalysis AT zhengc transarterialchemoembolizationplusradiofrequencyablationandiodine125seedimplantationforhepatocellularcarcinomainhighrisklocationsapropensityscorematchedanalysis AT kanx transarterialchemoembolizationplusradiofrequencyablationandiodine125seedimplantationforhepatocellularcarcinomainhighrisklocationsapropensityscorematchedanalysis |